Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)

NACompletedINTERVENTIONAL
Enrollment

1,140

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

August 31, 2019

Conditions
Patient CompliancePatient Adherence
Interventions
BEHAVIORAL

Motivational interview

Patients assigned to the intervention group receive additional medical consultation aiming to boost optimal uptake of the anticoagulation regimen prescribed. Initially (i.e., at hospital discharge), this includes a physician-patient interactive session and provision of an educational leaflet. The leaflet is designed in a culturally and linguistically conceivable template in Greek language. It uses simple terms together with both written and pictorial materials. Patients in the intervention group will also undergo short telephonic sessions at 1 week, 2 months, 6 months and 12 months following hospital discharge

BEHAVIORAL

Control

Patients assigned to the control group receive usual treatment, corresponding to standard practice and management of hospitalized patients with AF. For both patient-groups, the choice of OAC agent and any other background therapy is left to the discretion of the treating physician.

Trial Locations (1)

54637

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

AHEPA University Hospital

OTHER

NCT02941978 - Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF) | Biotech Hunter | Biotech Hunter